Cronos Group Reports 2021 Second Quarter Results
August 06, 2021 07:30 ET
|
Cronos Group Inc.
Amended agreement with Ginkgo Bioworks to accelerate commercialization of cultured cannabinoids Announced strategic investment in PharmaCann, a leading U.S. cannabis company Spinach™ launched new...
Cronos Group Launches Delicious New Dual-Flavor Cannabis Gummies
July 29, 2021 07:00 ET
|
Cronos Group Inc.
SOURZ by Spinach™ gummies offer adult consumers a bold and juicy new cannabis edible featuring great tasting dual flavors and dual colors TORONTO, July 29, 2021 (GLOBE NEWSWIRE) -- Cronos Group...
Cronos Group Inc. to Hold 2021 Second Quarter Earnings Conference Call on August 6, 2021
July 23, 2021 08:00 ET
|
Cronos Group Inc.
TORONTO, July 23, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will hold its 2021 Second Quarter Earnings Conference Call on Friday, August...
Cronos Group Inc. Announces Results of 2021 Annual Meeting of Shareholders
June 25, 2021 16:05 ET
|
Cronos Group Inc.
TORONTO, June 25, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) announces that at its Annual Meeting of Shareholders held earlier today (the...
Cronos Group Announces Strategic Investment in PharmaCann, a Leading U.S. Cannabis Company
June 14, 2021 07:30 ET
|
Cronos Group Inc.
Investment is Expected to Position Cronos Group to Benefit from Rapid Growth in the U.S. Cannabis Market PharmaCann is Well Positioned in Limited License States Across the Midwest and Northeast ...
Cronos Group and Ginkgo Bioworks Amend Agreement to Accelerate Commercialization of Cultured Cannabinoids and Cronos Group Begins Commercial Production of CBG
June 04, 2021 07:30 ET
|
Cronos Group Inc.
BOSTON and TORONTO, June 04, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group”), an innovative global cannabinoid company, and Ginkgo Bioworks, Inc. (“Ginkgo”),...
Cronos Group Inc. to Participate in Canaccord Genuity’s 5th Annual Global Cannabis Conference on May 11, 2021
May 10, 2021 13:00 ET
|
Cronos Group Inc.
TORONTO, May 10, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike...
Cronos Group Launches Marketing Code to Drive Responsibility Within the Cannabis Industry
May 10, 2021 07:00 ET
|
Cronos Group Inc.
TORONTO and LOS ANGELES, May 10, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today released a Marketing Code designed to responsibly move...
Cronos Group Reports 2021 First Quarter Results
May 07, 2021 07:30 ET
|
Cronos Group Inc.
Receives processing license for the commercial production and sale of cannabinoids using biosynthesis Announces plans to launch Spinach™ branded edibles to the Canadian adult-use market ...
Cronos Group Inc. to Hold Virtual 2021 Annual Meeting of Shareholders
April 28, 2021 08:00 ET
|
Cronos Group Inc.
TORONTO, April 28, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will hold its 2021 Annual Meeting of Shareholders on Friday, June 25, 2021,...